Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Devriese

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
Oral Oncology|November 8, 2021
Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancerS I Bril, N Chargi, A W Wendrich, et al.
Investigational New Drugs|May 5, 2012
Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazoleL A Devriese, M Mergui-Roelvink, J Wanders, et al.
Oral Oncology|August 7, 2024
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysisA W M A Schaeffers, H A Scholten, M A van Beers, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2012
Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairmentL A Devriese, P O Witteveen, S Marchetti, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2022
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literatureJ M van Berge Henegouwen, H van der Wijngaart, L J Zeverijn, et al.
Head & Neck|April 23, 2026
Predominance of In-Field Recurrence After Radiotherapy for Sinonasal Cancer: A Single-Center Retrospective StudyM de Ridder, L J van de Velde, T de Bie, et al.
British Journal of Cancer|August 21, 2015
Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumoursB Milojkovic Kerklaan, M P J Lolkema, L A Devriese, et al.
ESMO Open|May 1, 2026
Real-world effectiveness of molecular-matched therapies in salivary gland cancerJ A M Weijers, N J van Ruitenbeek, A C H van Engen-van Grunsven, et al.
Nature|October 2, 2019
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugsD L van der Velden, L R Hoes, H van der Wijngaart, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Oral Oncology|November 8, 2021
Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancerS I Bril, N Chargi, A W Wendrich, et al.
Investigational New Drugs|May 5, 2012
Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazoleL A Devriese, M Mergui-Roelvink, J Wanders, et al.
Oral Oncology|August 7, 2024
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysisA W M A Schaeffers, H A Scholten, M A van Beers, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2012
Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairmentL A Devriese, P O Witteveen, S Marchetti, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2022
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literatureJ M van Berge Henegouwen, H van der Wijngaart, L J Zeverijn, et al.
Head & Neck|April 23, 2026
Predominance of In-Field Recurrence After Radiotherapy for Sinonasal Cancer: A Single-Center Retrospective StudyM de Ridder, L J van de Velde, T de Bie, et al.
British Journal of Cancer|August 21, 2015
Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumoursB Milojkovic Kerklaan, M P J Lolkema, L A Devriese, et al.
ESMO Open|May 1, 2026
Real-world effectiveness of molecular-matched therapies in salivary gland cancerJ A M Weijers, N J van Ruitenbeek, A C H van Engen-van Grunsven, et al.
Nature|October 2, 2019
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugsD L van der Velden, L R Hoes, H van der Wijngaart, et al.
Pageof 23